AIM ImmunoTech Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
AIM ImmunoTech Inc. announced that it has received a notice from the NYSE American indicating that it is not in compliance with certain continued listing standards regarding stockholders' equity due ...
AIM ImmunoTech Inc. plans to regain compliance with NYSE equity requirements by June 2026, focusing on oncology and antiviral advancements. The company is under scrutiny from the NYSE American for ...
LONDON - Artemis Resources Limited (ASX/AIM:ARV) announced Thursday it will cancel its admission to trading on the AIM market of the London Stock Exchange, with the delisting expected to take effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results